Aaron Ehlinger

Company: Abbvie

Job title: Principal Research Scientist

Seminars:

Exploring the Cytokinome: Leveraging Fragment-Based Screening for Difficult-to-Drug Targets 8:30 am

Taking a combined approach to evaluating different screening techniques for hit identification within the cytokinome Diving into fragment-based screening and its role in supporting the drug discovery process Showcasing how fragment-based screening provides deeper insights into target biology for difficult-to-drug targetsRead more

day: Day One

Panel Discussion: From Diversity to Novelty – Upgrading Library Designs for High-Throughput Screening 1:30 pm

Constructing diverse compound libraries with a focus on novel chemotypes for large-scale screening Perfecting our understanding of DELs to expand chemical diversity and coverage of target classes Determining the most appropriate libraries for a given target to maximize hit opportunityRead more

day: Day One